| Shareholder Report | 12 Months Ended |
| Jul. 31, 2024 USD ($) $ / shares |
| Shareholder Report [Line Items] | | |
| Document Type | N-CSR/A | |
| Amendment Flag | false | |
| Registrant Name | Franklin
Global Trust | |
| Entity Central Index Key | 0001124459 | |
| Entity Investment Company Type | N-1A | |
| Document Period End Date | Jul. 31, 2024 | |
| Class A | | |
| Shareholder Report [Line Items] | | |
| Fund Name | Franklin
International Growth Fund | |
| Class Name | Class
A | |
| Trading Symbol | FNGAX | |
| Annual or Semi-Annual Statement [Text Block] | This
annual
shareholder report
contains important information about Franklin
International Growth Fund for the period August
1, 2023, to July 31, 2024. | |
| Shareholder Report Annual or Semi-Annual | annual
shareholder report | |
| Additional Information [Text Block] | You
can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents .
You can also request this information
by contacting us at (800)
DIAL BEN/342-5236 . | |
| Material Fund Change Notice [Text Block] | This report describes changes
to the Fund that occurred during the reporting period. | |
| Additional Information Phone Number | (800)
DIAL BEN/342-5236 | |
| Additional Information Website | https://www.franklintempleton.com/regulatory-fund-documents | |
| Expenses [Text Block] | WHAT
WERE THE FUND COSTS FOR THE LAST YEAR? (based
on a hypothetical $10,000 investment)
Class
Name
Costs
of a $10,000 investment
Costs
paid as a percentage of a $10,000
investment *
Class
A
$114
1.11% | [1] |
| Expenses Paid, Amount | $ 114 | |
| Expense Ratio, Percent | 1.11% | |
| Factors Affecting Performance [Text Block] | HOW
DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE? For the twelve months ended July
31, 2024, Class A shares of
Franklin International Growth
Fund returned 6.00%. The
Fund compares its performance
to the MSCI EAFE Index-NR, which returned 11.21% for the same period. PERFORMANCE
HIGHLIGHTS
Top
contributors to performance:
↑
Information
technology holding, Keywords Studios, a U.K.-listed provider of creative, technical and player-support services to the video
game industry, on the news that it may be acquired by a European private equity group
↑
In
financials, U.K.-based asset management firm Intermediate Capital Group following fiscal 2024 results that exceeded consensus
estimates
↑
Shares
of CyberArk Software, a provider of identity security software solutions based in the U.S., after the company reported first-quarter
2024 financials that exceeded both revenue and earnings consensus estimates
Top
detractors from performance:
↓
Shares
of Evotec, a German biotechnology contract development and manufacturing company, as management’s outlook for 2024 profit
was more cautious than consensus expectations
↓
In
financials, shares of the Dutch online payments firm Adyen moved lower after its first half 2023 financial report indicated slowing
growth in North America
↓
Genmab,
a Danish biotechnology company, as investors expected the phase-out of its treatment for multiple myeloma, Darzalex, to
restrain future revenue growth | |
| Performance Past Does Not Indicate Future [Text] | The
Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. | |
| Line Graph [Table Text Block] | | |
| Average Annual Return [Table Text Block] | AVERAGE
ANNUAL TOTAL RETURNS (%) Period
Ended July 31, 2024
1
Year
5
Year
10
Year
Class
A
6.00
4.87
5.49
Class
A (with sales charge)
0.17
3.69
4.90
MSCI
All Country World ex-US Index-NR
9.75
6.29
4.18
MSCI
EAFE Index-NR
11.21
7.35
4.84 | |
| No Deduction of Taxes [Text Block] | The
graph and table do not reflect
the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares. | |
| Updated Performance Information Location [Text Block] | For current month-end performance,
please call Franklin Templeton at (800)
DIAL BEN/342-5236 or visit https://www.franklintempleton.com/investments/options/mutual-funds . Important data provider notices
and terms available at www.franklintempletondatasources.com . | |
| Net Assets | $ 1,016,026,021 | |
| Holdings Count | $ / shares | 34 | [2] |
| Advisory Fees Paid, Amount | $ 7,848,350 | |
| Investment Company Portfolio Turnover | 17.56% | |
| Additional Fund Statistics [Text Block] | KEY
FUND STATISTICS (as
of July 31, 2024)
Total
Net Assets
$1,016,026,021
Total
Number of Portfolio Holdings *
34
Total
Management Fee Paid
$7,848,350
Portfolio
Turnover Rate
17.56% | [2] |
| Holdings [Text Block] | | |
| Material Fund Change [Text Block] | HOW
HAS THE FUND CHANGED? On December 1, 2023, disclosure
was added to the Fund’s principal investment strategies to reflect the Fund’s increased exposure to securities
in the health care sector. Related disclosure regarding
the risks of investing in securities in the health care sector was also added to the Fund’s principal risks. This is a summary of certain
changes to the Fund since August 1, 2023. For more complete information, you may review the Fund’s current
prospectus and any applicable supplements and the Fund’s next prospectus, which we expect to be available by December 1, 2024,
at https://www.franklintempleton.com/regulatory-fund-documents
or upon request at (800)
DIAL BEN/342-5236
or prospectus franklintempleton.com . | |
| Updated Prospectus Phone Number | (800)
DIAL BEN/342-5236 | |
| Updated Prospectus Email Address | prospectus@franklintempleton.com | |
| Updated Prospectus Web Address | https://www.franklintempleton.com/regulatory-fund-documents | |
| Class C | | |
| Shareholder Report [Line Items] | | |
| Fund Name | Franklin
International Growth Fund | |
| Class Name | Class
C | |
| Trading Symbol | FNGDX | |
| Annual or Semi-Annual Statement [Text Block] | This
annual
shareholder report
contains important information about Franklin
International Growth Fund for the period August
1, 2023, to July 31, 2024. | |
| Shareholder Report Annual or Semi-Annual | annual
shareholder report | |
| Additional Information [Text Block] | You
can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents .
You can also request this information
by contacting us at (800)
DIAL BEN/342-5236 . | |
| Material Fund Change Notice [Text Block] | This report describes changes
to the Fund that occurred during the reporting period. | |
| Additional Information Phone Number | (800)
DIAL BEN/342-5236 | |
| Additional Information Website | https://www.franklintempleton.com/regulatory-fund-documents | |
| Expenses [Text Block] | WHAT
WERE THE FUND COSTS FOR THE LAST YEAR? (based
on a hypothetical $10,000 investment)
Class
Name
Costs
of a $10,000 investment
Costs
paid as a percentage of a $10,000
investment *
Class
C
$191
1.86% | [3] |
| Expenses Paid, Amount | $ 191 | |
| Expense Ratio, Percent | 1.86% | |
| Factors Affecting Performance [Text Block] | HOW
DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE? For the twelve months ended July
31, 2024, Class C shares of
Franklin International Growth
Fund returned 5.19%. The
Fund compares its performance
to the MSCI EAFE Index-NR, which returned 11.21% for the same period. PERFORMANCE
HIGHLIGHTS
Top
contributors to performance:
↑
Information
technology holding, Keywords Studios, a U.K.-listed provider of creative, technical and player-support services to the video
game industry, on the news that it may be acquired by a European private equity group
↑
In
financials, U.K.-based asset management firm Intermediate Capital Group following fiscal 2024 results that exceeded consensus
estimates
↑
Shares
of CyberArk Software, a provider of identity security software solutions based in the U.S., after the company reported first-quarter
2024 financials that exceeded both revenue and earnings consensus estimates
Top
detractors from performance:
↓
Shares
of Evotec, a German biotechnology contract development and manufacturing company, as management’s outlook for 2024 profit
was more cautious than consensus expectations
↓
In
financials, shares of the Dutch online payments firm Adyen moved lower after its first half 2023 financial report indicated slowing
growth in North America
↓
Genmab,
a Danish biotechnology company, as investors expected the phase-out of its treatment for multiple myeloma, Darzalex, to
restrain future revenue growth | |
| Performance Past Does Not Indicate Future [Text] | The
Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. | |
| Line Graph [Table Text Block] | | |
| Average Annual Return [Table Text Block] | AVERAGE
ANNUAL TOTAL RETURNS (%) Period
Ended July 31, 2024
1
Year
5
Year
10
Year
Class
C
5.19
4.09
4.70
Class
C (with sales charge)
4.19
4.09
4.70
MSCI
All Country World ex-US Index-NR
9.75
6.29
4.18
MSCI
EAFE Index-NR
11.21
7.35
4.84 | |
| No Deduction of Taxes [Text Block] | The
graph and table do not reflect
the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares. | |
| Updated Performance Information Location [Text Block] | For current month-end performance,
please call Franklin Templeton at (800)
DIAL BEN/342-5236 or visit https://www.franklintempleton.com/investments/options/mutual-funds . Important data provider notices
and terms available at www.franklintempletondatasources.com . | |
| Net Assets | $ 1,016,026,021 | |
| Holdings Count | $ / shares | 34 | [4] |
| Advisory Fees Paid, Amount | $ 7,848,350 | |
| Investment Company Portfolio Turnover | 17.56% | |
| Additional Fund Statistics [Text Block] | KEY
FUND STATISTICS (as
of July 31, 2024)
Total
Net Assets
$1,016,026,021
Total
Number of Portfolio Holdings *
34
Total
Management Fee Paid
$7,848,350
Portfolio
Turnover Rate
17.56% | [4] |
| Holdings [Text Block] | | |
| Material Fund Change [Text Block] | HOW
HAS THE FUND CHANGED? On December 1, 2023, disclosure
was added to the Fund’s principal investment strategies to reflect the Fund’s increased exposure to securities
in the health care sector. Related disclosure regarding
the risks of investing in securities in the health care sector was also added to the Fund’s principal risks. This is a summary of certain
changes to the Fund since August 1, 2023. For more complete information, you may review the Fund’s current
prospectus and any applicable supplements and the Fund’s next prospectus, which we expect to be available by December 1, 2024,
at https://www.franklintempleton.com/regulatory-fund-documents
or upon request at (800)
DIAL BEN/342-5236
or prospectus franklintempleton.com . | |
| Updated Prospectus Phone Number | (800)
DIAL BEN/342-5236 | |
| Updated Prospectus Email Address | prospectus@franklintempleton.com | |
| Updated Prospectus Web Address | https://www.franklintempleton.com/regulatory-fund-documents | |
| Class R | | |
| Shareholder Report [Line Items] | | |
| Fund Name | Franklin
International Growth Fund | |
| Class Name | Class
R | |
| Trading Symbol | FNGRX | |
| Annual or Semi-Annual Statement [Text Block] | This
annual
shareholder report
contains important information about Franklin
International Growth Fund for the period August
1, 2023, to July 31, 2024. | |
| Shareholder Report Annual or Semi-Annual | annual
shareholder report | |
| Additional Information [Text Block] | You
can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents .
You can also request this information
by contacting us at (800)
DIAL BEN/342-5236 . | |
| Material Fund Change Notice [Text Block] | This report describes changes
to the Fund that occurred during the reporting period. | |
| Additional Information Phone Number | (800)
DIAL BEN/342-5236 | |
| Additional Information Website | https://www.franklintempleton.com/regulatory-fund-documents | |
| Expenses [Text Block] | WHAT
WERE THE FUND COSTS FOR THE LAST YEAR? (based
on a hypothetical $10,000 investment)
Class
Name
Costs
of a $10,000 investment
Costs
paid as a percentage of a $10,000
investment *
Class
R
$140
1.36% | [5] |
| Expenses Paid, Amount | $ 140 | |
| Expense Ratio, Percent | 1.36% | |
| Factors Affecting Performance [Text Block] | HOW
DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE? For the twelve months ended July
31, 2024, Class R shares of
Franklin International Growth
Fund returned 5.74%. The
Fund compares its performance
to the MSCI EAFE Index-NR, which returned 11.21% for the same period. PERFORMANCE
HIGHLIGHTS
Top
contributors to performance:
↑
Information
technology holding, Keywords Studios, a U.K.-listed provider of creative, technical and player-support services to the video
game industry, on the news that it may be acquired by a European private equity group
↑
In
financials, U.K.-based asset management firm Intermediate Capital Group following fiscal 2024 results that exceeded consensus
estimates
↑
Shares
of CyberArk Software, a provider of identity security software solutions based in the U.S., after the company reported first-quarter
2024 financials that exceeded both revenue and earnings consensus estimates
Top
detractors from performance:
↓
Shares
of Evotec, a German biotechnology contract development and manufacturing company, as management’s outlook for 2024 profit
was more cautious than consensus expectations
↓
In
financials, shares of the Dutch online payments firm Adyen moved lower after its first half 2023 financial report indicated slowing
growth in North America
↓
Genmab,
a Danish biotechnology company, as investors expected the phase-out of its treatment for multiple myeloma, Darzalex, to
restrain future revenue growth | |
| Performance Past Does Not Indicate Future [Text] | The
Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. | |
| Line Graph [Table Text Block] | | |
| Average Annual Return [Table Text Block] | AVERAGE
ANNUAL TOTAL RETURNS (%) Period
Ended July 31, 2024
1
Year
5
Year
10
Year
Class
R
5.74
4.61
5.23
MSCI
All Country World ex-US Index-NR
9.75
6.29
4.18
MSCI
EAFE Index-NR
11.21
7.35
4.84 | |
| No Deduction of Taxes [Text Block] | The
graph and table do not reflect
the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares. | |
| Updated Performance Information Location [Text Block] | For current month-end performance,
please call Franklin Templeton at (800)
DIAL BEN/342-5236 or visit https://www.franklintempleton.com/investments/options/mutual-funds . Important data provider notices
and terms available at www.franklintempletondatasources.com . | |
| Net Assets | $ 1,016,026,021 | |
| Holdings Count | $ / shares | 34 | [6] |
| Advisory Fees Paid, Amount | $ 7,848,350 | |
| Investment Company Portfolio Turnover | 17.56% | |
| Additional Fund Statistics [Text Block] | KEY
FUND STATISTICS (as
of July 31, 2024)
Total
Net Assets
$1,016,026,021
Total
Number of Portfolio Holdings *
34
Total
Management Fee Paid
$7,848,350
Portfolio
Turnover Rate
17.56% | [6] |
| Holdings [Text Block] | | |
| Material Fund Change [Text Block] | HOW
HAS THE FUND CHANGED? On December 1, 2023, disclosure
was added to the Fund’s principal investment strategies to reflect the Fund’s increased exposure to securities
in the health care sector. Related disclosure regarding
the risks of investing in securities in the health care sector was also added to the Fund’s principal risks. This is a summary of certain
changes to the Fund since August 1, 2023. For more complete information, you may review the Fund’s current
prospectus and any applicable supplements and the Fund’s next prospectus, which we expect to be available by December 1, 2024,
at https://www.franklintempleton.com/regulatory-fund-documents
or upon request at (800)
DIAL BEN/342-5236
or prospectus franklintempleton.com . | |
| Updated Prospectus Phone Number | (800)
DIAL BEN/342-5236 | |
| Updated Prospectus Email Address | prospectus@franklintempleton.com | |
| Updated Prospectus Web Address | https://www.franklintempleton.com/regulatory-fund-documents | |
| Class R6 | | |
| Shareholder Report [Line Items] | | |
| Fund Name | Franklin
International Growth Fund | |
| Class Name | Class
R6 | |
| Trading Symbol | FILRX | |
| Annual or Semi-Annual Statement [Text Block] | This
annual
shareholder report
contains important information about Franklin
International Growth Fund for the period August
1, 2023, to July 31, 2024. | |
| Shareholder Report Annual or Semi-Annual | annual
shareholder report | |
| Additional Information [Text Block] | You
can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents .
You can also request this information
by contacting us at (800)
DIAL BEN/342-5236 . | |
| Material Fund Change Notice [Text Block] | This report describes changes
to the Fund that occurred during the reporting period. | |
| Additional Information Phone Number | (800)
DIAL BEN/342-5236 | |
| Additional Information Website | https://www.franklintempleton.com/regulatory-fund-documents | |
| Expenses [Text Block] | WHAT
WERE THE FUND COSTS FOR THE LAST YEAR? (based
on a hypothetical $10,000 investment)
Class
Name
Costs
of a $10,000 investment
Costs
paid as a percentage of a $10,000
investment *
Class
R6
$77
0.75% | [7] |
| Expenses Paid, Amount | $ 77 | |
| Expense Ratio, Percent | 0.75% | |
| Factors Affecting Performance [Text Block] | HOW
DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE? For the twelve months ended July
31, 2024, Class R6 shares of
Franklin International Growth
Fund returned 6.35%. The
Fund compares its performance
to the MSCI EAFE Index-NR, which returned 11.21% for the same period. PERFORMANCE
HIGHLIGHTS
Top
contributors to performance:
↑
Information
technology holding, Keywords Studios, a U.K.-listed provider of creative, technical and player-support services to the video
game industry, on the news that it may be acquired by a European private equity group
↑
In
financials, U.K.-based asset management firm Intermediate Capital Group following fiscal 2024 results that exceeded consensus
estimates
↑
Shares
of CyberArk Software, a provider of identity security software solutions based in the U.S., after the company reported first-quarter
2024 financials that exceeded both revenue and earnings consensus estimates
Top
detractors from performance:
↓
Shares
of Evotec, a German biotechnology contract development and manufacturing company, as management’s outlook for 2024 profit
was more cautious than consensus expectations
↓
In
financials, shares of the Dutch online payments firm Adyen moved lower after its first half 2023 financial report indicated slowing
growth in North America
↓
Genmab,
a Danish biotechnology company, as investors expected the phase-out of its treatment for multiple myeloma, Darzalex, to
restrain future revenue growth | |
| Performance Past Does Not Indicate Future [Text] | The
Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. | |
| Line Graph [Table Text Block] | | |
| Average Annual Return [Table Text Block] | AVERAGE
ANNUAL TOTAL RETURNS (%) Period
Ended July 31, 2024
1
Year
5
Year
10
Year
Class
R6
6.35
5.26
5.91
MSCI
All Country World ex-US Index-NR
9.75
6.29
4.18
MSCI
EAFE Index-NR
11.21
7.35
4.84 | |
| No Deduction of Taxes [Text Block] | The
graph and table do not reflect
the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares. | |
| Updated Performance Information Location [Text Block] | For current month-end performance,
please call Franklin Templeton at (800)
DIAL BEN/342-5236 or visit https://www.franklintempleton.com/investments/options/mutual-funds . Important data provider notices
and terms available at www.franklintempletondatasources.com . | |
| Net Assets | $ 1,016,026,021 | |
| Holdings Count | $ / shares | 34 | [8] |
| Advisory Fees Paid, Amount | $ 7,848,350 | |
| Investment Company Portfolio Turnover | 17.56% | |
| Additional Fund Statistics [Text Block] | KEY
FUND STATISTICS (as
of July 31, 2024)
Total
Net Assets
$1,016,026,021
Total
Number of Portfolio Holdings *
34
Total
Management Fee Paid
$7,848,350
Portfolio
Turnover Rate
17.56% | [8] |
| Holdings [Text Block] | | |
| Material Fund Change [Text Block] | HOW
HAS THE FUND CHANGED? On December 1, 2023, disclosure
was added to the Fund’s principal investment strategies to reflect the Fund’s increased exposure to securities
in the health care sector. Related disclosure regarding
the risks of investing in securities in the health care sector was also added to the Fund’s principal risks. This is a summary of certain
changes to the Fund since August 1, 2023. For more complete information, you may review the Fund’s current
prospectus and any applicable supplements and the Fund’s next prospectus, which we expect to be available by December 1, 2024,
at https://www.franklintempleton.com/regulatory-fund-documents
or upon request at (800)
DIAL BEN/342-5236
or prospectus franklintempleton.com . | |
| Updated Prospectus Phone Number | (800)
DIAL BEN/342-5236 | |
| Updated Prospectus Email Address | prospectus@franklintempleton.com | |
| Updated Prospectus Web Address | https://www.franklintempleton.com/regulatory-fund-documents | |
| Advisor Class | | |
| Shareholder Report [Line Items] | | |
| Fund Name | Franklin
International Growth Fund | |
| Class Name | Advisor
Class | |
| Trading Symbol | FNGZX | |
| Annual or Semi-Annual Statement [Text Block] | This
annual
shareholder report
contains important information about Franklin
International Growth Fund for the period August
1, 2023, to July 31, 2024. | |
| Shareholder Report Annual or Semi-Annual | annual
shareholder report | |
| Additional Information [Text Block] | You
can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents .
You can also request this information
by contacting us at (800)
DIAL BEN/342-5236 . | |
| Material Fund Change Notice [Text Block] | This report describes changes
to the Fund that occurred during the reporting period. | |
| Additional Information Phone Number | (800)
DIAL BEN/342-5236 | |
| Additional Information Website | https://www.franklintempleton.com/regulatory-fund-documents | |
| Expenses [Text Block] | WHAT
WERE THE FUND COSTS FOR THE LAST YEAR? (based
on a hypothetical $10,000 investment)
Class
Name
Costs
of a $10,000 investment
Costs
paid as a percentage of a $10,000
investment *
Advisor
Class
$89
0.86% | [9] |
| Expenses Paid, Amount | $ 89 | |
| Expense Ratio, Percent | 0.86% | |
| Factors Affecting Performance [Text Block] | HOW
DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE? For the twelve months ended July
31, 2024, Advisor Class shares
of Franklin International Growth
Fund returned 6.26%. The
Fund compares its performance
to the MSCI EAFE Index-NR, which returned 11.21% for the same period. PERFORMANCE
HIGHLIGHTS
Top
contributors to performance:
↑
Information
technology holding, Keywords Studios, a U.K.-listed provider of creative, technical and player-support services to the video
game industry, on the news that it may be acquired by a European private equity group
↑
In
financials, U.K.-based asset management firm Intermediate Capital Group following fiscal 2024 results that exceeded consensus
estimates
↑
Shares
of CyberArk Software, a provider of identity security software solutions based in the U.S., after the company reported first-quarter
2024 financials that exceeded both revenue and earnings consensus estimates
Top
detractors from performance:
↓
Shares
of Evotec, a German biotechnology contract development and manufacturing company, as management’s outlook for 2024 profit
was more cautious than consensus expectations
↓
In
financials, shares of the Dutch online payments firm Adyen moved lower after its first half 2023 financial report indicated slowing
growth in North America
↓
Genmab,
a Danish biotechnology company, as investors expected the phase-out of its treatment for multiple myeloma, Darzalex, to
restrain future revenue growth | |
| Performance Past Does Not Indicate Future [Text] | The
Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. | |
| Line Graph [Table Text Block] | | |
| Average Annual Return [Table Text Block] | AVERAGE
ANNUAL TOTAL RETURNS (%) Period
Ended July 31, 2024
1
Year
5
Year
10
Year
Advisor
Class
6.26
5.13
5.76
MSCI
All Country World ex-US Index-NR
9.75
6.29
4.18
MSCI
EAFE Index-NR
11.21
7.35
4.84 | |
| No Deduction of Taxes [Text Block] | The
graph and table do not reflect
the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares. | |
| Updated Performance Information Location [Text Block] | For current month-end performance,
please call Franklin Templeton at (800)
DIAL BEN/342-5236 or visit https://www.franklintempleton.com/investments/options/mutual-funds . Important data provider notices
and terms available at www.franklintempletondatasources.com . | |
| Net Assets | $ 1,016,026,021 | |
| Holdings Count | $ / shares | 34 | [10] |
| Advisory Fees Paid, Amount | $ 7,848,350 | |
| Investment Company Portfolio Turnover | 17.56% | |
| Additional Fund Statistics [Text Block] | KEY
FUND STATISTICS (as
of July 31, 2024)
Total
Net Assets
$1,016,026,021
Total
Number of Portfolio Holdings *
34
Total
Management Fee Paid
$7,848,350
Portfolio
Turnover Rate
17.56% | [10] |
| Holdings [Text Block] | | |
| Material Fund Change [Text Block] | HOW
HAS THE FUND CHANGED? On December 1, 2023, disclosure
was added to the Fund’s principal investment strategies to reflect the Fund’s increased exposure to securities
in the health care sector. Related disclosure regarding
the risks of investing in securities in the health care sector was also added to the Fund’s principal risks. This is a summary of certain
changes to the Fund since August 1, 2023. For more complete information, you may review the Fund’s current
prospectus and any applicable supplements and the Fund’s next prospectus, which we expect to be available by December 1, 2024,
at https://www.franklintempleton.com/regulatory-fund-documents
or upon request at (800)
DIAL BEN/342-5236
or prospectus franklintempleton.com . | |
| Updated Prospectus Phone Number | (800)
DIAL BEN/342-5236 | |
| Updated Prospectus Email Address | prospectus@franklintempleton.com | |
| Updated Prospectus Web Address | https://www.franklintempleton.com/regulatory-fund-documents | |
| Advisor Class | | |
| Shareholder Report [Line Items] | | |
| Fund Name | Franklin
Emerging Market Debt Opportunities Fund | |
| Class Name | Advisor
Class | |
| Trading Symbol | FEMDX | |
| Annual or Semi-Annual Statement [Text Block] | This
annual
shareholder report
contains important information about Franklin
Emerging Market Debt Opportunities Fund for the period August
1, 2023, to July 31, 2024. | |
| Shareholder Report Annual or Semi-Annual | annual
shareholder report | |
| Additional Information [Text Block] | You
can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents .
You can also request this information
by contacting us at (800)
321-8563 . | |
| Additional Information Phone Number | (800)
321-8563 | |
| Additional Information Website | https://www.franklintempleton.com/regulatory-fund-documents | |
| Expenses [Text Block] | WHAT
WERE THE FUND COSTS FOR THE LAST YEAR? (based
on a hypothetical $10,000 investment)
Class
Name
Costs
of a $10,000 investment
Costs
paid as a percentage of a $10,000
investment *
Advisor
Class
$107
1.00% | [11] |
| Expenses Paid, Amount | $ 107 | |
| Expense Ratio, Percent | 1% | |
| Factors Affecting Performance [Text Block] | HOW
DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE? For the twelve months ended July
31, 2024, Advisor Class shares
of Franklin Emerging Market Debt Opportunities Fund returned 13.78%.
The Fund compares its performance to the JP Morgan EMBI Global Diversified Index, the JP Morgan EMBI Global Diversified ex-GCC
Index, the JP Morgan GBI-EM Broad Diversified Index benchmark and the ICE BofA Emerging Market Corporate Plus (USD Hedged)
Index, which returned 9.18%, 10.08%, 0.71% and 8.88%, respectively, for the same period. PERFORMANCE
HIGHLIGHTS
Top
contributors to performance:
↑
Allocation
to Surinamese U.S.-dollar bonds, the prices of which increased on the back of the country’s finalizing its U.S. $675 million
debt exchange
↑
Allocation
to Mozambique U.S.-dollar bonds, as the Fund received compensation following a settlement with Credit Suisse/UBS bank
Top
detractors from performance:
↓
Exposure
to the Brazilian real, which weakened due to the unwinding of investor positioning
↓
Exposure
to the Mexican peso, which depreciated amid volatility related to the presidential and legislative elections Use of derivatives and the
impact on performance: Currency derivatives, used to
hedge the portfolio’s eastern European currency exposure back to the euro, provided a minimal contribution. | |
| Performance Past Does Not Indicate Future [Text] | The
Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. | |
| Line Graph [Table Text Block] | | |
| Average Annual Return [Table Text Block] | AVERAGE
ANNUAL TOTAL RETURNS (%) Period
Ended July 31, 2024
1
Year
5
Year
10
Year
Advisor
Class
13.78
3.71
4.06
Bloomberg
Global Aggregate Index
3.00
-1.43
-0.06
JP
Morgan EMBI Global Diversified Index
9.18
0.10
2.75
JP
Morgan EMBI Global Diversified ex-GCC Index 1
10.08
-0.31
N/A
JP
Morgan GBI-EM Broad Diversified Index
0.71
-0.08
0.48
ICE
BofA Emerging Market Corporate Plus (USD Hedged) Index
8.88
1.07
2.85 | [12] |
| No Deduction of Taxes [Text Block] | The
graph and table do not reflect
the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares. | |
| Updated Performance Information Location [Text Block] | For current month-end performance,
please call Franklin Templeton at (800)
321-8563 or visit https://www.franklintempleton.com/ investments/options/mutual-funds . Important data provider notices
and terms available at www.franklintempletondatasources.com . | |
| Net Assets | $ 68,317,824 | |
| Holdings Count | $ / shares | 98 | [13] |
| Advisory Fees Paid, Amount | $ 275,120 | |
| Investment Company Portfolio Turnover | 75.07% | |
| Additional Fund Statistics [Text Block] | KEY
FUND STATISTICS (as
of July 31, 2024)
Total
Net Assets
$68,317,824
Total
Number of Portfolio Holdings *
98
Total
Management Fee Paid
$275,120
Portfolio
Turnover Rate
75.07% | [13] |
| Holdings [Text Block] | | |
| Updated Prospectus Web Address | https://www.franklintempleton.com/regulatory-fund-documents | |
|
[1]
* Reflects
fee waivers and/or expense reimbursements, without which expenses would have been higher.
* Does
not include derivatives, except purchased options, if any.
* Reflects
fee waivers and/or expense reimbursements, without which expenses would have been higher.
* Does
not include derivatives, except purchased options, if any.
* Reflects
fee waivers and/or expense reimbursements, without which expenses would have been higher.
* Does
not include derivatives, except purchased options, if any.
* Reflects
fee waivers and/or expense reimbursements, without which expenses would have been higher.
* Does
not include derivatives, except purchased options, if any.
* Reflects
fee waivers and/or expense reimbursements, without which expenses would have been higher.
* Does
not include derivatives, except purchased options, if any.
* Reflects
fee waivers and/or expense reimbursements, without which expenses would have been higher.
1 Due
to data availability, performance for the JPM EMBI Global Diversified ex-GCC Index is shown starting 12/31/15 using the Fund’s
value on that date. Values prior
to 12/31/2015 reflect the performance of the Fund.
* Does
not include derivatives, except purchased options, if any. |
